CSIMarket
 
Endra Life Sciences Inc  (NASDAQ: NDRA)
 

Endra Life Sciences Inc's Customers Performance

NDRA



 
NDRA's Source of Revenues

List of NDRA Customers




for the same period Endra Life Sciences Inc

List of NDRA Customers





Endra Life Sciences Inc's Comment on Sales, Marketing and Customers



The company faces regulatory challenges involving oversight by the FDA and FTC. It also encounters difficulties in enrolling participants for clinical trials, which may affect its business operations and financial condition.


  News about Endra Life Sciences Inc Contracts

Endra Life Sciences Bounces Back Regaining Compliance Amidst Market Struggles

In a notable turn of events for Endra Life Sciences Inc. the Ann Arbor-based innovator of Thermo Acoustic Enhanced UltraSound (TAEUS), the company has successfully reclaimed compliance with the Nasdaq s minimum bid price requirement. On November 21, 2024, Endra announced that it received a notification from the Nasdaq Listing Qualifications Department confirming adherence to Listing Rule 5550(a)(2). This pivotal development enables the company to remain listed on one of the world’s foremost exchanges, signaling a promising moment for both the firm and its stakeholders.However, the news comes against a backdrop of turbulent market performance for Endra, which has seen its shares decline a staggering 87.46% ...

ENDRA Life Sciences Empowers Precision Medicine with Groundbreaking TAEUS Liver System Installation at King's College Hospital NHS Foundation Trust

TAEUS Liver System Installed at King s College Hospital NHS Foundation Trust, Proving ENDRA Life Sciences Commitment to InnovationENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in Thermo Acoustic Enhanced UltraSound (TAEUS), has reached a significant milestone in its quest to revolutionize medical imaging. The company recently announced the installation of its TAEUS liver system at King s College Hospital NHS Foundation Trust (KCH) in London, a renowned center of excellence within the United Kingdom s National Health Service (NHS).KCH will employ ENDRA s TAEUS liver system in a comprehensive clinical study, aiming to compare its liver fat assessment accuracy with magnetic resonance imaging (MRI), the wi...

ENDRA Life Sciences Transforms Healthcare with Breakthrough TAEUS Ultrasound Technology and Strong Financial Growth

ENDRA Life Sciences Reports Strong Financial Results and Promising Business Updates
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a ground-breaking company in Thermo Acoustic Enhanced UltraSound (TAEUS), has announced its financial results for the third quarter and nine months ending on September 30, 2023, along with exciting developments in its business operations. This period has been marked by significant advancements and achievements that underline the company s commitment to revolutionizing the healthcare industry through innovative ultrasound technology.
One of the highlights of the third quarter of 2023 was ENDRA Life Sciences sharing positive TAEUS clinical data at the prestigious Steatotic Liver...




Endra Life Sciences Inc’s Comment on Sales, Marketing and Customers


The company faces regulatory challenges involving oversight by the FDA and FTC. It also encounters difficulties in enrolling participants for clinical trials, which may affect its business operations and financial condition.








NDRA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Endra Life Sciences Inc 13.12 0.00 -5.17 4
SUBTOTAL 0.00 0.00 0.00 -

Sources: Endra Life Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Endra Life Sciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Endra Life Sciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.